Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

$Thumbnail for Belantamab Mafodotin Triplets Versus Active-Control Triplets in Relapsed or Refractory Multiple Myeloma$

MM - 1277

Belantamab Mafodotin Triplets Versus Active-Control Triplets in Relapsed or Refractory Multiple Myeloma

Vasu Malhotra

Poster Presenter: Vasu Malhotra

Thumbnail for Prognostic Impact of TP53 Disruption in Richter Transformation: A Systematic Review and Hazard Ratio Meta-Analysis of Survival Outcomes

CLL - 1278

Prognostic Impact of TP53 Disruption in Richter Transformation: A Systematic Review and Hazard Ratio Meta-Analysis of Survival Outcomes

Aima Azhar

Poster Presenter: Aima Azhar

Thumbnail for KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

Previous 1...102 103 104 105 106 107 108...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MPN - 1280

KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

Dongni Yi

Poster Presenter: Dongni Yi

Thumbnail for Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

CLL - 1282

Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials

Rishi Nanda

Poster Presenter: Rishi Nanda

Thumbnail for Direct Oral Anticoagulants Versus Warfarin in Philadelphia-Negative Myeloproliferative Neoplasms With Atrial Fibrillation: A Propensity-Matched Retrospective Cohort Study

MPN - 1283

Direct Oral Anticoagulants Versus Warfarin in Philadelphia-Negative Myeloproliferative Neoplasms With Atrial Fibrillation: A Propensity-Matched Retrospective Cohort Study

Anmol Kumar

Poster Presenter: Anmol Kumar

Thumbnail for Baseline Protein-Energy Malnutrition Identifies a High-Risk Phenotype in HMA-Treated Myelodysplastic Syndromes: A Propensity-Matched Real-World Analysis

MDS - 1284

Baseline Protein-Energy Malnutrition Identifies a High-Risk Phenotype in HMA-Treated Myelodysplastic Syndromes: A Propensity-Matched Real-World Analysis

Sooraj Srirangadhamu Gopu

Poster Presenter: Sooraj Srirangadhamu Gopu

Thumbnail for Trends and Disparities in Inpatient Systemic Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the United States, 2016-2022

CLL - 1285

Trends and Disparities in Inpatient Systemic Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the United States, 2016-2022

Xiaoyi Zhang

Poster Presenter: Xiaoyi Zhang

Thumbnail for Nivolumab+AVD versus eBEACOPP in advanced-stage classic Hodgkin lymphoma. Single-center, non-randomized, prospective clinical trial. Real clinical practice.

HL - 1286

Nivolumab+AVD versus eBEACOPP in advanced-stage classic Hodgkin lymphoma. Single-center, non-randomized, prospective clinical trial. Real clinical practice.

Diana Ivanova

Poster Presenter: Diana Ivanova

Thumbnail for Failure-to-Rescue and Critical Illness Phenotypes in Acute Myeloid Leukemia Hospitalizations With Sepsis: A National Inpatient Sample Analysis

AML - 1291

Failure-to-Rescue and Critical Illness Phenotypes in Acute Myeloid Leukemia Hospitalizations With Sepsis: A National Inpatient Sample Analysis

Daniel Thomas Jones

Poster Presenter: Daniel Thomas Jones

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors